| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.1M | -22.7% |
| SG&A Expense | $53.7M | -6.8% |
| Pre-tax Income | -$84.7M | -9.3% |
| Income Tax | $0 | — |
| Net Income | -$84.7M | -9.3% |
| EPS (Basic) | -$0.54 | +28.0% |
| EPS (Diluted) | -$0.54 | +28.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $63.9M | +91.2% |
| Current Assets | $236.2M | -31.6% |
| Total Assets | $861.3M | +29.6% |
| Current Liabilities | $38.3M | -0.4% |
| Long-term Debt | $249.6M | +0.0% |
| Total Liabilities | $350.5M | +23.8% |
| Stockholders' Equity | $510.9M | +33.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$65.5M | -20.1% |
| Capital Expenditures | $287.2M | +109.0% |
| Investing Cash Flow | -$218.4M | +28.5% |
| Financing Cash Flow | $247.5M | -15.6% |
| Free Cash Flow | -$352.7M | -83.8% |